IP Library Granted Patent US 8,470,970
Granted Patent B2
US 8,470,970 · App. 12/944,515 · Granted Jun 25, 2013

Mammalian sweet and amino acid heterodimeric taste receptors comprising T1R3 and T1R1

Inventors: Charles S. Zuker (New York, NY); Jayaram Chandrashekar (San Diego, CA); Greg Nelson (San Diego, CA); Yifeng Zhang (Boston, MA); Nicholas J. P. Ryba (Bethesda, MD); Mark A. Hoon (Kensington, MD)
Assignees: The Regents of the University of California; The Government of the United States of America
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,470,970
App. No.
12/944,515
Granted
Jun 25, 2013
Kind
B2
Abstract

The present invention provides isolated nucleic acid and amino acid sequences of sweet or amino acid taste receptors comprising T1R3 and T1R1, two heterologous G-protein coupled receptor polypeptides from the T1R family of sensory G-protein coupled receptors, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of sweet and amino acid taste receptors.

Claims (23)

1. An isolated or recombinant polypeptide, wherein the polypeptide comprises an extracellular region and a transmembrane region, wherein

(a) the extracellular region is selected from the group consisting of: an amino acid sequence that has at least 93% amino acid sequence identity to the extracellular region of SEQ ID NO:20 or an amino acid sequence that has at least 94% amino acid sequence identity to the extracellular region of SEQ ID NO:23, or an amino acid sequence of an extracellular region of another GPCR, and

(b) the transmembrane region is selected from the group consisting of: an amino acid sequence that has at least 93% amino acid sequence identity to the transmembrane region of SEQ ID NO:20 or has at least 94% amino acid sequence identity to the transmembrane region of SEQ ID NO:23, or an amino acid sequence of a transmembrane region of another GPCR,

wherein at least one of the extracellular region and the transmembrane region comprises at least 93% amino acid sequence identity to the extracellular region or the transmembrane region of SEQ ID NO:20 or at least 94% amino acid sequence identity to the extracellular region or the transmembrane region of SEQ ID NO:23.

2. The isolated or recombinant polypeptide of claim 1 , wherein the polypeptide comprises the extracellular region of SEQ ID NO:20 or 23 and the transmembrane region of another GPCR polypeptide.

3. The isolated or recombinant polypeptide of claim 1 , wherein the polypeptide comprises the transmembrane region of SEQ ID NO:20 or 23 and the extracellular region of another GPCR polypeptide.

4. The isolated or recombinant polypeptide of claim 1 , wherein the extracellular region has at least 93% amino acid sequence identity to the extracellular region of SEQ ID NO:20 and the transmembrane region has at least 94% amino acid sequence identity to the transmembrane region of SEQ ID NO:23.

5. The isolated or recombinant polypeptide of claim 1 , wherein the transmembrane region has at least 93% amino acid sequence identity to the transmembrane region of SEQ ID NO:20 and the extracellular region has at least 94% amino acid sequence identity to the extracellular region of SEQ ID NO:23.

6. The isolated or recombinant polypeptide of claim 1 , wherein the polypeptide comprises the extracellular region of SEQ ID NO:23 and the transmembrane region of SEQ ID NO:20.

7. The isolated or recombinant polypeptide of claim 1 , wherein the polypeptide comprises the extracellular region of SEQ ID NO:20 and the transmembrane region of SEQ ID NO:23.

8. The isolated or recombinant polypeptide of claim 1 , wherein the polypeptide comprises the extracellular region of SEQ ID NO:20 and the transmembrane region of another GPCR polypeptide.

9. The isolated or recombinant polypeptide of claim 1 , wherein the polypeptide comprises the extracellular region of another GPCR polypeptide and the transmembrane region of SEQ ID NO:20.

10. The isolated or recombinant polypeptide of claim 1 , wherein the polypeptide comprises the extracellular region of SEQ ID NO:23 and the transmembrane region of another GPCR polypeptide.

11. The isolated or recombinant polypeptide of claim 1 , wherein the polypeptide comprises the extracellular region of another GPCR polypeptide and the transmembrane region of SEQ ID NO:23.

12. A host cell expressing the isolated or recombinant polypeptide as in any one of claims 1 - 5 .

13. The host cell of claim 12 , wherein the host cell is a mammalian cell.

14. The host cell of claim 12 , wherein the host cell is a human cell.

15. An isolated or recombinant polypeptide, wherein the polypeptide comprises an extracellular region and a transmembrane region, wherein the extracellular region has an amino acid sequence having at least 90% amino acid sequence identity to the extracellular region of SEQ ID NO:2 and the transmembrane region has an amino acid sequence of another GPCR polypeptide or the extracellular region has an amino acid sequence of another GPCR polypeptide and the transmembrane region has an amino acid sequence having at least 90% amino acid sequence identity to the transmembrane region of SEQ ID NO:2.

16. The isolated or recombinant polypeptide of claim 15 , wherein the extracellular region has the amino acid sequence of the extracellular region of SEQ ID NO:2.

17. The isolated or recombinant polypeptide of claim 15 , wherein the transmembrane region has the amino acid sequence of the transmembrane region of SEQ ID NO:2.

18. A host cell expressing the isolated or recombinant polypeptide of claim 15 .

19. The host cell of claim 18 , wherein the host cell is a mammalian cell.

20. The host cell of claim 18 , wherein the host cell is a human cell.

Assignments (3)
CONFIRMATORY LICENSE Recorded Aug 18, 2011
From: UNIVERSITY OF CALIFORNIA SAN DIEGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026769/0241 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2011
From: RYBA, NICHOLAS J.P.; HOON, MARK A.
To: THE GOVERNMENT OF THE UNITED STATES OF AMERICA
Reel/Frame 025639/0508 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2011
From: ZUKER, CHARLES S.; NELSON, GREGORY A.; CHANDRASHEKAR, JAYARAM; ZHANG, YIFENG
To: THE REGENT OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 025634/0576 →
Continuity (6)
Continuation 12121576 · May 15, 2008
Continuation 10190417 · Jul 3, 2002
Continuation In Part 09927315 · Aug 10, 2001
Provisional Application 60358925 · Feb 22, 2002
Provisional Application 60302898 · Jul 3, 2001
Related Publication 20110151483A1 · Jun 23, 2011